CASIRIVIMAB\IMDEVIMAB for Upper respiratory tract infection: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 13 adverse event reports in the FDA FAERS database where CASIRIVIMAB\IMDEVIMAB was used for Upper respiratory tract infection.
Most Reported Side Effects for CASIRIVIMAB\IMDEVIMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Infusion related reaction | 875 | 20.6% | 4 | 178 |
| Dyspnoea | 687 | 16.2% | 14 | 322 |
| Nausea | 416 | 9.8% | 1 | 115 |
| Oxygen saturation decreased | 390 | 9.2% | 15 | 281 |
| Dizziness | 357 | 8.4% | 4 | 66 |
| Pyrexia | 306 | 7.2% | 4 | 146 |
| Chest discomfort | 294 | 6.9% | 0 | 44 |
| Chills | 265 | 6.2% | 4 | 107 |
| Flushing | 238 | 5.6% | 0 | 16 |
| Cough | 235 | 5.5% | 2 | 116 |
| Hypoxia | 222 | 5.2% | 8 | 184 |
| Incorrect dose administered | 220 | 5.2% | 2 | 48 |
| Hyperhidrosis | 214 | 5.0% | 4 | 51 |
| Hypotension | 211 | 5.0% | 7 | 79 |
| Chest pain | 208 | 4.9% | 1 | 73 |
Other Indications for CASIRIVIMAB\IMDEVIMAB
Covid-19 (2,943)
Product used for unknown indication (256)
Covid-19 treatment (208)
Sars-cov-2 test positive (199)
Covid-19 prophylaxis (51)
Covid-19 pneumonia (38)
Exposure to sars-cov-2 (17)
Post-acute covid-19 syndrome (12)
Prophylaxis (9)
Sars-cov-2 antibody test positive (9)
Other Drugs Used for Upper respiratory tract infection
LEVOFLOXACIN (448)
AMOXICILLIN (235)
AZITHROMYCIN (196)
IBUPROFEN (194)
AZITHROMYCIN ANHYDROUS (188)
CLARITHROMYCIN (158)
AMOXICILLIN\CLAVULANATE (135)
ACETAMINOPHEN (128)
AMOXICILLIN\CLAVULANIC ACID (128)
ALBUTEROL (103)